{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:28:14Z","timestamp":1771306094560,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310113\/2017-2"],"award-info":[{"award-number":["310113\/2017-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bbr.2021.113512","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T11:39:47Z","timestamp":1627990787000},"page":"113512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Behavioral and neurochemical effects of folic acid in a mouse model of depression induced by TNF-\u03b1"],"prefix":"10.1016","volume":"414","author":[{"given":"Josiane","family":"Budni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgana","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5342-0477","authenticated-orcid":false,"given":"Andiara E.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian B.","family":"Neis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grasiela","family":"de Oliveira Balen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora K.","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2536-6888","authenticated-orcid":false,"given":"Rodrigo B.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-8780","authenticated-orcid":false,"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2021.113512_bib0005","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2215-0366(16)30031-1","article-title":"Investing in global mental health: the time for action is now","volume":"3","author":"Summergrad","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbr.2021.113512_bib0010","first-page":"87","article-title":"Cost of depression in Europe","volume":"9","author":"Sobocki","year":"2006","journal-title":"J. Ment. Health Policy Econ."},{"key":"10.1016\/j.bbr.2021.113512_bib0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/hup.288","article-title":"Expanding the horizons of depression: beyond the monoamine hypothesis","volume":"16","author":"Hindmarch","year":"2001","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.bbr.2021.113512_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2020.04.076","article-title":"Inflammation at the interface of physical and neuropsychiatric outcomes: investigation of neuroendocrine regulatory pathways to inform therapeutics","author":"Hong","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2021.113512_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder","volume":"61","author":"Hashimoto","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbr.2021.113512_bib0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of Interferon-\u03b1 in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2021.113512_bib0035","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biopsych.2008.08.010","article-title":"Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression","volume":"65","author":"Raison","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113512_bib0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ahj.2004.08.029","article-title":"Depressive symptoms and inflammation among heart failure patients","volume":"150","author":"Ferketich","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbr.2021.113512_bib0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbi.2015.08.012","article-title":"Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease","volume":"50","author":"Hong","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2021.113512_bib0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF02193091","article-title":"Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol","volume":"245","author":"Maes","year":"1995","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbr.2021.113512_bib0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbapap.2005.08.017","article-title":"MAPK signalling pathways as molecular targets for anti-inflammatory therapy\u2014from molecular mechanisms to therapeutic benefits","volume":"1754","author":"Kaminska","year":"2005","journal-title":"Biochim. Biophys. Acta BBA - Proteins Proteomics"},{"key":"10.1016\/j.bbr.2021.113512_bib0060","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.euroneuro.2015.03.006","article-title":"TNF-\u03b1-induced depressive-like phenotype and p38(MAPK) activation are abolished by ascorbic acid treatment","volume":"25","author":"Moretti","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2021.113512_bib0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1196\/annals.1410.076","article-title":"Corticosterone regulates pERK1\/2 map kinase in a chronic depression model","volume":"1148","author":"Gourley","year":"2008","journal-title":"Ann. Acad. Med. Sci."},{"key":"10.1016\/j.bbr.2021.113512_bib0070","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1523\/JNEUROSCI.17-18-07166.1997","article-title":"Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1","volume":"17","author":"Ericsson","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2021.113512_bib0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-0-585-37970-8_8","article-title":"Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress","volume":"461","author":"Dunn","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbr.2021.113512_bib0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF03033069","article-title":"Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response","volume":"247","author":"Maes","year":"1997","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbr.2021.113512_bib0085","article-title":"Stress-induced cytokine changes in rats","author":"Himmerich","year":"2013","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bbr.2021.113512_bib0090","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuropharm.2011.08.018","article-title":"Depressive-like behavior induced by tumor necrosis factor-alpha in mice","volume":"62","author":"Kaster","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2021.113512_bib0095","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O\u2019Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113512_bib0100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2012.10.002","article-title":"A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?","volume":"67","author":"Walker","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2021.113512_bib0105","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bbr.2021.113512_bib0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpsychires.2017.07.019","article-title":"The association of folate and depression: a meta-analysis","volume":"95","author":"Bender","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2021.113512_bib0115","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0006-3223(89)90266-7","article-title":"Folate, B12, and life course of depressive illness","volume":"25","author":"Levitt","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113512_bib0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-0327(00)00153-1","article-title":"Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial","volume":"60","author":"Coppen","year":"2000","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbr.2021.113512_bib0125","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0140-6736(90)91942-4","article-title":"Enhancement of recovery from psychiatric illness by methylfolate","volume":"336","author":"Godfrey","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2021.113512_bib0130","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1176\/appi.ajp.2012.11071114","article-title":"L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials","volume":"169","author":"Papakostas","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113512_bib0135","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.neuropharm.2007.10.016","article-title":"Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems","volume":"54","author":"Brocardo","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2021.113512_bib0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2012.10.024","article-title":"Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice","volume":"240","author":"Budni","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2021.113512_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2014.10.003","article-title":"Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice","volume":"127","author":"Rosa","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2021.113512_bib0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbr.2009.01.004","article-title":"Evidence for the involvement of the opioid system in the antidepressant-like effect of folic acid in the mouse forced swimming test","volume":"200","author":"Brocardo","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2021.113512_bib0155","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0269881111424456","article-title":"Involvement of PI3K, GSK-3\u03b2 and PPAR\u03b3 in the antidepressant-like effect of folic acid in the forced swimming test in mice","volume":"26","author":"Budni","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2021.113512_bib0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/35072566","article-title":"Research and treatment approaches to depression","volume":"2","author":"Wong","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbr.2021.113512_bib0165","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.euroneuro.2016.03.009","article-title":"Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling","volume":"26","author":"Neis","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2021.113512_bib0170","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2013.12.038","article-title":"Depressive-like behavior induced by tumor necrosis factor-alpha is abolished by agmatine administration","volume":"261C","author":"Neis","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2021.113512_bib0175","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","article-title":"NO as a signalling molecule in the nervous system","volume":"135","author":"Esplugues","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2021.113512_bib0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.bbr.2021.113512_bib0185","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jpsychires.2011.11.009","article-title":"Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress","volume":"46","author":"Moretti","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2021.113512_bib0190","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbr.2011.07.024","article-title":"Involvement of nitric oxide\u2013cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test","volume":"225","author":"Moretti","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2021.113512_bib0195","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0003-2697(77)90043-4","article-title":"A simplification of the protein assay method of Lowry et al. which is more generally applicable","volume":"83","author":"Peterson","year":"1977","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbr.2021.113512_bib0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","article-title":"Cytokines and major depression","volume":"29","author":"Schiepers","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113512_bib0205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.eurpsy.2008.03.013","article-title":"Depression, comorbidities and the TNF-alpha system","volume":"23","author":"Himmerich","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113512_bib0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","article-title":"Cytokine-associated emotional and cognitive disturbances in humans","volume":"58","author":"Reichenberg","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113512_bib0215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbi.2010.10.010","article-title":"Cytokine levels in the blood may distinguish suicide attempters from depressed patients","volume":"25","author":"Janelidze","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2021.113512_bib0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","article-title":"Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue","volume":"81","author":"Enache","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2021.113512_bib0225","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","article-title":"Inflammation-associated depression: from serotonin to kynurenine","volume":"36","author":"Dantzer","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbr.2021.113512_bib0230","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1210\/endo-126-6-2876","article-title":"Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat","volume":"126","author":"Bernardini","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbr.2021.113512_bib0235","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuroscience.2005.02.023","article-title":"An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission","volume":"133","author":"Reynolds","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2021.113512_bib0240","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1124\/jpet.104.067835","article-title":"Brain-derived tumor necrosis factor-alpha and its involvement in noradrenergic neuron functioning involved in the mechanism of action of an antidepressant","volume":"310","author":"Reynolds","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2021.113512_bib0245","first-page":"19","article-title":"L-methylfolate plus SSRI or SNRI from treatment initiation compared to SSRI or SNRI monotherapy in a major depressive episode","volume":"8","author":"Ginsberg","year":"2011","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.bbr.2021.113512_bib0250","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2013.13010084","article-title":"Methylfolate as adjunctive treatment in major depression","volume":"170","author":"Reynolds","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113512_bib0255","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/0269881105048899","article-title":"Treatment of depression: time to consider folic acid and vitamin B12","volume":"19","author":"Coppen","year":"2005","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"10.1016\/j.bbr.2021.113512_bib0260","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbb.2011.12.008","article-title":"Role of potassium channels in the antidepressant-like effect of folic acid in the forced swimming test in mice","volume":"101","author":"Budni","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2021.113512_bib0265","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nut.2018.03.006","article-title":"\u03c9-3 and folic acid act against depressive-like behavior and oxidative damage in the brain of rats subjected to early- or late-life stress","volume":"53","author":"R\u00e9us","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/j.bbr.2021.113512_bib0270","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pharep.2015.10.003","article-title":"Augmentation of effect of venlafaxine by folic acid in behavioral paradigms of depression in mice: evidence of serotonergic and pro-inflammatory cytokine pathways","volume":"68","author":"Thomas","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbr.2021.113512_bib0275","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.69.2.228","article-title":"Homocysteine, folate, methylation, and monoamine metabolism in depression","volume":"69","author":"Bottiglieri","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113512_bib0280","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1017\/S0033291700038447","article-title":"Folate deficiency, biopterin and monoamine metabolism in depression","volume":"22","author":"Bottiglieri","year":"1992","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbr.2021.113512_bib0285","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.biopsych.2007.04.014","article-title":"Direct inhibitory effect of fluoxetine on N-methyl-D-aspartate receptors in the central nervous system","volume":"62","author":"Szasz","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2021.113512_bib0290","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2008.08.033","article-title":"Antidepressant-like effect of folic acid: involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway","volume":"598","author":"Brocardo","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2021.113512_bib0295","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2021.113512_bib0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2014.12.009","article-title":"Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice","volume":"130","author":"Neis","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2021.113512_bib0305","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0197-0186(03)00163-3","article-title":"Protein kinase C alpha requirement in the activation of p38 mitogen-activated protein kinase, which is linked to the induction of tumor necrosis factor alpha in lipopolysaccharide-stimulated microglia","volume":"44","author":"Nakajima","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2021.113512_bib0310","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1213\/01.ane.0000287660.29297.7b","article-title":"The influence of p38 mitogen-activated protein kinase inhibitor on synthesis of inflammatory cytokine tumor necrosis factor alpha in spinal cord of rats with chronic constriction injury","volume":"105","author":"Xu","year":"2007","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.bbr.2021.113512_bib0315","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuropharm.2011.07.020","article-title":"Selective modulation of the PKC\u03b5\/p38MAP kinase signalling pathway for the antidepressant-like activity of amitriptyline","volume":"62","author":"Galeotti","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2021.113512_bib0320","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.neuropharm.2011.04.033","article-title":"Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells","volume":"61","author":"Liu","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2021.113512_bib0325","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jad.2017.10.019","article-title":"Swimming exercise reverses CUMS-induced changes in depression-like behaviors and hippocampal plasticity-related proteins","volume":"227","author":"Liu","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbr.2021.113512_bib0330","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbr.2017.01.035","article-title":"Up-regulation of SIRT6 in the hippocampus induced rats with depression-like behavior via the block Akt\/GSK3\u03b2 signaling pathway","volume":"323","author":"Mao","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2021.113512_bib0335","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00213-018-5087-1","article-title":"Resveratrol exerts a protective effect in chronic unpredictable mild stress-induced depressive-like behavior: involvement of the AKT\/GSK3\u03b2 signaling pathway in hippocampus","volume":"236","author":"Shen","year":"2019","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2021.113512_bib0340","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11011-019-0389-5","article-title":"Antidepressive effects of kaempferol mediated by reduction of oxidative stress, proinflammatory cytokines and up-regulation of AKT\/\u03b2-catenin cascade","volume":"34","author":"Gao","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbr.2021.113512_bib0345","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000356517","article-title":"Akt mediates GSK-3\u03b2 phosphorylation in the rat prefrontal cortex during the process of ketamine exerting rapid antidepressant actions","volume":"21","author":"Zhou","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.bbr.2021.113512_bib0350","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbr.2007.11.012","article-title":"Involvement of glutathione, ERK1\/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats","volume":"188","author":"Franco","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2021.113512_bib0355","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2014.07.024","article-title":"Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice","volume":"58","author":"Freitas","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2021.113512_bib0360","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.nbd.2008.05.003","article-title":"Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress","volume":"31","author":"Qi","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2021.113512_bib0365","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-008-1306-5","article-title":"Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation","volume":"201","author":"Li","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2021.113512_bib0370","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1523-1755.2005.00569.x","article-title":"CREB mediates ERK-induced survival of mouse renal tubular cells after oxidant stress","volume":"68","author":"Arany","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbr.2021.113512_bib0375","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1399-5618.2010.00827.x","article-title":"Folic acid administration prevents ouabain-induced hyperlocomotion and alterations in oxidative stress markers in the rat brain","volume":"12","author":"Brocardo","year":"2010","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbr.2021.113512_bib0380","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/jnbs.jnbs_32_20","article-title":"Vitamin B12 and folic acid in depression and anxiety: a pilot study","volume":"7","author":"Erensoy","year":"2020","journal-title":"J. Neurobehav. Sci."},{"key":"10.1016\/j.bbr.2021.113512_bib0385","series-title":"Handbook of Clinical Neurology, Neurologic Aspects of Systemic Disease Part II","first-page":"927","article-title":"Chapter 61 - The neurology of folic acid deficiency","author":"Reynolds","year":"2014"},{"key":"10.1016\/j.bbr.2021.113512_bib0390","article-title":"Folic acid and Parkinson disease","volume":"287","author":"Vastag","year":"2002","journal-title":"JAMA"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432821004009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432821004009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:33:17Z","timestamp":1759066397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432821004009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":78,"alternative-id":["S0166432821004009"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2021.113512","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral and neurochemical effects of folic acid in a mouse model of depression induced by TNF-\u03b1","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2021.113512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113512"}}